Zydus Wellness has announced a board meeting approving the audited consolidated financial results for the quarter and year ended March 31, 2025. Consolidated revenue hit ₹2,722.5 Cr with a net profit of ₹347 Cr, showing solid year-on-year growth. The board proposed a final dividend of ₹6 per share, pending shareholder approval. Key strategic moves include acquiring Naturell (India) Private Limited and starting voluntary winding-up of a subsidiary. A share split from ₹10 to ₹2 per share was also approved, awaiting shareholder consent. The company is focused on manufacturing efficiency and streamlining its brand portfolio.